(88 days)
Not Found
No
The description focuses on mechanical components and a modification for easier cleaning, with no mention of AI or ML.
Yes.
The device is used for High Dose Rate (HDR) irradiation, which is a therapeutic treatment for cancers of the uterus and cervix.
No
This device is an applicator used for delivering high dose rate irradiation for cancer treatment, not for diagnosing medical conditions.
No
The device description clearly details physical components like applicators, rings, tandems, build-up caps, and a rectal retractor, indicating it is a hardware device used in brachytherapy. The modification described is also a change to a physical component (the rectal retractor).
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "High Dose Rate irradiation of the uterus and cervix." This is a therapeutic application, not a diagnostic one.
- Device Description: The device is described as a "delivery system for the administration of high dose rate irradiation." This further reinforces its therapeutic purpose.
- Lack of Diagnostic Function: The description focuses on the physical components and their role in delivering radiation. There is no mention of analyzing samples (blood, tissue, etc.) or providing diagnostic information about a patient's condition.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Mick Radio-Nuclear Instruments, Inc. CT HDR Tandem/Ring Applicator with Rectal Retractor is intended for use in Brachytherapy. It is indicated for use where high dose rate (HDR) irradiation of the uterus and cervix is an accepted clinical practice. The applicator is designed to be compatible with the sealed sources found in High Dose Rate After-Loaders and do not modify or change the source, source packaging or remote source positioning mechanisms found on these after-loaders.
The Mick Radio-Nuclear Instruments, Inc. CT HDR Tandem/Ring Applicator with Rectal Retractor is indicated for High Dose Rate irradiation of the uterus and cervix. The modification that precipitated this Special 510(k) does not alter the indications for use.
Product codes (comma separated list FDA assigned to the subject device)
JAQ
Device Description
The applicator presents a stable and flexible delivery system for the administration of high dose rate irradiation of cancers of the uterus and cervix. The applicator offers several treatment options by including three different angles of Rings (30°, 45° & 60°) and nine different Tandems. The Tandems are offered in complementary angles to the three rings and in three different Tandem lengths for each angle (2cm, 4cm & 6cm from the ring axis). In addition, there are two sizes of Build-Up Caps (5mm & 7.5mm) that affix to the Rings that offer shielding to patient tissue and a Rectal Retractor is included. The entire applicator system is housed in a specially designed Sterilization Cassette, meant for both storage and sterilization. This applicator has been cleared by FDA since 2003.
The modification presented in this Special 510(k) allows for the removal of the paddle portion of the Rectal Retractor from the Rectal Retractor assembly. This facilitates easier cleaning by the user to prevent potential build-up of soil in the paddle. There are no other impacts to the applicator system in this modification. The intended use is unchanged.
The modification to a two-piece Rectal Retractor design is controlled through the Mick Radio-Nuclear design controls and is manufactured onsite at Mick Radio-Nuclear Instruments, Inc. The two-piece Rectal Retractor design does not introduce any new risks or potential negative impacts to the overall performance of the applicator.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
uterus and cervix
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Test Results
- a. In vitro Testing Not applicable to the modification for the device. By introducing this device, no new issues of safety or effectiveness are raised.
- b. In vivo Testing Not applicable for the modification for the device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5700 Remote controlled radionuclide applicator system.
(a)
Identification. A remote controlled radionuclide applicator system is an electromechanical or pneumatic device intended to enable an operator to apply, by remote control, a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories.(b)
Classification. Class II.
0
DEC 1 4 2012
Special 510(k) Summary for compliance with CFR 807.92
September 12, 2012
1. General Provisions
| Common Name: | Remote Controlled Radionuclide Applicator System (21 CFR 892.5700 - Product Code JAQ) |
|---|---|
| Proprietary Name: | CT HDR Tandem/Ring Applicator with Rectal Retractor |
| Owner Name | Mick Radio-Nuclear Instruments, Inc. |
| Address | 521 Homestead Avenue |
| Mount Vernon, New York 10550 | |
| Telephone | (914) 667-3999 |
| Fax | (914) 665-8834 |
| Contact Name | Chuck Smith |
| Contact email | chuck@micknuclear.com |
2. Name of Predicate Device:
| Device | Manufacturer | K Number |
|---|---|---|
| CT HDR Tandem/Ring | ||
| Applicator with Rectal Retractor | Mick Radio-Nuclear Instruments, Inc. | K030110 |
Reason for this Special 510(k) Premarket Notification 3.
The purpose of this Special 510(k) submission is to obtain clearance to market the CT HDR Tandem/Ring Applicator with Rectal Retractor (Catalog # 0407), with a modified two-piece Rectal Retractor.
ﺎﻧﻬﺎ ﻓﻬ
4. Classification
This device is classified as a class II device according to 21 CFR 892.5700 .
1
5. Intended Use and Device Description
The Mick Radio-Nuclear Instruments, Inc. CT HDR Tandem/Ring Applicator with Rectal Retractor is intended for use in Brachytherapy. It is indicated for use where high dose rate (HDR) irradiation of the uterus and cervix is an accepted clinical practice. The applicator is designed to be compatible with the sealed sources found in High Dose Rate After-Loaders and do not modify or change the source, source packaging or remote source positioning mechanisms found on these after-loaders.
The applicator presents a stable and flexible delivery system for the administration of high dose rate irradiation of cancers of the uterus and cervix. The applicator offers several treatment options by including three different angles of Rings (30°, 45° & 60°) and nine different Tandems. The Tandems are offered in complementary angles to the three rings and in three different Tandem lengths for each angle (2cm, 4cm & 6cm from the ring axis). In addition, there are two sizes of Build-Up Caps (5mm & 7.5mm) that affix to the Rings that offer shielding to patient tissue and a Rectal Retractor is included. The entire applicator system is housed in a specially designed Sterilization Cassette, meant for both storage and sterilization. This applicator has been cleared by FDA since 2003.
The modification presented in this Special 510(k) allows for the removal of the paddle portion of the Rectal Retractor from the Rectal Retractor assembly. This facilitates easier cleaning by the user to prevent potential build-up of soil in the paddle. There are no other impacts to the applicator system in this modification. The intended use is unchanged.
The modification to a two-piece Rectal Retractor design is controlled through the Mick Radio-Nuclear design controls and is manufactured onsite at Mick Radio-Nuclear Instruments, Inc. The two-piece Rectal Retractor design does not introduce any new risks or potential negative impacts to the overall performance of the applicator.
6. Drawings
Schematic diagrams of the CT HDR Tandem / Ring Applicator with Rectal Retractor are provided in Tab I.
7. Manufacturing Process
This device is manufactured according to Good Manufacturing Practices (GMPs) as defined in 21CFR part 820. The processes used to fabricate these devices are similar to those used for the predicate device described in this 510(k) notification.
Biocompatibility 8.
No new issues of biocompatibility are raised with regard to the modification of the Rectal Retractor of this device.
2
9. Summary of Substantial Equivalence
This device is similar in design and construction, utilizes the identical materials, and has the same intended use and performance characteristics to the predicate device. The modification to a two-piece Rectal Retractor incorporates a titanium mounting bracket and two additional titanium screws to affix the paddle to the Rectal Retractor assembly. The same grade of titanium used in the previous Rectal Retractor assembly is used for the additional components. The fundamental scientific technology is unchanged from the original predicate device. No new issues of safety or effectiveness are introduced by using this device.
Performance Test Results
- a. In vitro Testing Not applicable to the modification for the device. By introducing this device, no new issues of safety or effectiveness are raised.
- b. In vivo Testing Not applicable for the modification for the device.
10. Summary of Similarities and Differences
The design similarities/differences between the Rectal Retractor modification in this device and the original predicate device is/are:
The devices have the same basic design with the exception of the removable paddle component in the Rectal Retractor;
The devices have the same intended use: The devices use the same materials:
A summary of the design controls in the modification of the Rectal Retractor are contained in Tab K.
3
· 11. Comparison Table
The Table below compares the modification of this device to the predicate device. Included in these tables are a comparison of the materials and intended uses of these devices.
| | CT HDR Tandem/Ring Applicator
with Rectal Retractor | Modification to the CT HDR
Tandem/Ring Applicator with Rectal
Retractor |
|----------------------------------------------|---------------------------------------------------------------------|-------------------------------------------------------------------------------|
| K Number | K030110 | To Be Determined |
| Intended Use | High dose rate brachytherapy treatment
of the uterus and cervix. | High dose rate brachytherapy treatment
of the uterus and cervix. |
| Shielding | No | No |
| Tandem Material | Titanium | Titanium |
| Colpostat
Material | Titanium | Titanium |
| Build-Up Cap
Material | Acetal | Acetal |
| Rectal Retractor
Paddle Material | Acetal | Acetal |
| Rectal Retractor
Paddle Mount
Material | Not Applicable | Titanium |
1
.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features a stylized image of an eagle with its wings spread, overlaid with three wavy lines. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle emblem.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
Mick Radio-Nuclear Instruments, Inc. % Mr. Chuck Smith Manager, Oulaity Assurance 521 Homestead Avenue MOUNT VERNON NY 10550
DEC 1 4 2012
Re: K122840
Trade/Device Name: CT HDR Tandem/Ring Applicator with Rectal Retractor Regulation Number: 21 CFR 892.5700 Regulation Name: Remote controlled radio-nuclide applicator system Regulatory Class: II Product Code: JAQ Dated: September 12, 2012 Received: September 17, 2012
Dear Mr. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2-Mr. Smith
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mary S. Pastel
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K122840
Device Name: CT HDR Tandem/Ring Applicator with Rectal Retractor
Indications for Use:
The Mick Radio-Nuclear Instruments, Inc. CT HDR Tandem/Ring Applicator with Rectal Retractor is indicated for High Dose Rate irradiation of the uterus and cervix. The modification that precipitated this Special 510(k) does not alter the indications for use.
Prescription Use (Part 21 CFR 801 Subpart D) · AND/OR
Over-The-Counter Use . (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Mary S pastel
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k)_
Page 1 of 1